The Dutch National Growth Fund will invest 124.5 million euros in a new Centre for Animal-Free Biomedical Translation (CPBT) to accelerate the transition to animal-free research over the next decade. The aim of the centre is to generate safer, more effective treatments, while reducing animal suffering. RIVM, in collaboration with Utrecht University, UMC Utrecht and Utrecht University of Applied Sciences, is one of the initiators of the centre and involved in strengthening the acceptance and use of animal-free biomedical innovations.